Suncombe Announces Gold Sponsorship and Exhibition at ABSANZ Conference 2025

Suncombe Announces Gold Sponsorship and Exhibition at ABSANZ Conference 2025

Suncombe, a global leader in bio-waste decontamination systems and sanitary process technologies, will proudly exhibit as a Gold Sponsor at the 13th ABSANZ Conference, taking place from 27th to 31st October 2025 at Waterview in Bicentennial Park, Sydney, Australia.

This year’s event, themed “Future-Proofing Biosafety: Adapting to a World of Disruption and Change”, will bring together global experts, regulators, and industry leaders to explore how biosafety and biosecurity can respond to evolving challenges. The conference is set to cover topics including advances in containment technologies, artificial intelligence in laboratories, and adapting to ever-changing regulatory frameworks.

Suncombe’s presence at the conference is part of the company’s longstanding commitment to advancing biosafety worldwide and part of its expansion plans in Australia and New Zealand. With over 60 years of experience serving the pharmaceutical and life science sectors, Suncombe has built a reputation for engineering and delivering sanitary-designed Effluent Decontamination Systems (EDS) that meet the highest safety standards.

The company’s systems are widely recognised for their technical robustness and flexibility. Every EDS is engineered to suit the specific application and operational environment of the client, whether in biopharmaceutical research, high-containment laboratories, or other critical facilities. This adaptability, coupled with the assurance of in-house design, manufacturing, and validation, allows Suncombe to support clients in addressing complex biosafety requirements without compromise.

Steve Overton, Operations Director at Suncombe, said, “We are delighted to return to ABSANZ this year as Gold Sponsors. The conference is an important platform for collaboration and discussion on the future of biosafety and biosecurity, and we are proud to contribute our knowledge and expertise.

“With more than six decades of experience in the pharmaceutical sector, Suncombe understands the importance of safety, reliability, and adaptability in high-containment environments.”

At ABSANZ 2025, Suncombe aims to engage with biosafety professionals across Australia, New Zealand, and beyond, sharing insights into its latest advancements in decontamination technology as part of its mission to support a safer, more sustainable future for the life sciences industry.

For more information about Suncombe visit https://suncombe.com.